View Older Stories View More Recent Stories
-
Tesla (TSLA) Will Be Next Big Bubble to Burst
-
Bull and Bears Lock Horns in Tesla (TSLA) Monday
-
UPDATE: Tesla (TSLA) Cut to Neutral at Lazard; Any Execution Issue May Send Stock to $100
-
Lazard Keeps Emulex (ELX) at Neutral; No Surprise in Q4 Results, No Improvement Expected Yet
-
Lazard Capital Downgrades Orbitz Worldwide Inc. (OWW) to Neutral
-
Streetinsider.com's Hot Lunchtime Reads 08/08: (JCP) (FDO) (MSFT) (CAT)
-
Lazard Cuts PT on Fusion-io (FIO) to $17; Company Now in 4th and Long Scenario
-
Lazard Still Neutral on Cisco (CSCO) Heading Into FQ4 Report; Sees Conservative Outlook
-
Streetinsider.com's Hot Lunchtime Reads 08/07: (GLUU) (USU) (TSLA) (ARUN) (GOOG)
-
Lazard Boosts PT on Aruba (ARUN) Into Q4 Results; Checks Indicate Potential Upside to Ests
-
Vanda Pharma (VNDA) Prices 4.68M Offering at $11.14/Share
-
Organovo Holdings (ONVO) Prices 9M Common Stock Offering
-
Lazard Boosts PT on Teradata (TDC) to $75; Q2 Results Solid, Weakness Not Co. Specific
-
Streetinsider.com's Hot Lunchtime Reads 08/01: (JCP) (AAPL) (APOL) (FCX) (RKUS)
-
Lazard Keeps Ruckus (RKUS) at Neutral Following Q2 Report; Caution Around SP Evident in Outlook
-
Lazard Keeps Buy Rating on Riverbed (RVBD) Following Q2; Core Still Intact Amid Challenges
-
Notable Analyst Rating Changes 07/31: (ALU) (CBST) (FWLT) Upgraded; (XYL) (IPI) (NVDA) Downgraded
-
Lazard Capital Upgrades Foster Wheeler (FWLT) to Buy
-
Notable 52-Week Highs and Lows of the Day 07/29: (FB) (IPG) (USU) High; (TRQ) (EXPE) Low
-
Rockwood Holdings (ROC) to Sell Clay Additives Business in $635M Deal
-
Lazard Capital Downgrades Expedia (EXPE) to Neutral
-
UPDATE: Lazard Capital Maintains Buy on Expedia (EXPE)
-
Lazard Capital Downgrades NxStage Medical (NXTM) to Neutral
-
UBS Upgrades Lazard (LAZ) to Neutral
-
Lazard Stays Neutral on QLogic (QLGC); Exit of Switching Positive, But Environment Still Weak
-
Lazard Capital Downgrades Quality Systems (QSII) to Sell
-
Lazard Raises PT on F5 (FFIV) to $100; Strong Position in ACE Refresh Cycle
-
Notable Analyst Rating Changes 07/25: (DCT) (DAL) (FB) Upgraded; (F) (CAT) (WLP) Downgraded
-
Lazard (LAZ) Tops Q2 EPS by 13c; Shares Surge 5%
-
Lazard Capital Downgrades Sequenom (SQNM) to Neutral
-
Trading Radar for 07/25: GM (GM), Dow (DOW), Hershey (HSY), Sirius (SIRI), Zynga (ZNGA) Report
-
Lazard (LAZ) Declares $0.25 Quarterly Dividend; 2.9% Yield
-
Lazard Maintains Buy on Apple (AAPL) Post-FQ3 Report; Older iPhone Sales Aren't Bad! No, Really!
-
Lazard Capital Downgrades Sourcefire (FIRE) to Neutral
-
Sourcefire (FIRE) is Net Positive for Cisco (CSCO), But More Purchases Needed - Lazard
-
Lazard Capital Starts Aratana Therapeutics (PETX) at Buy
-
Insmed (INSM) Closes 6M IPO at $10.40/Share
-
Lazard Capital Downgrades athenahealth (ATHN) to Neutral
-
Notable Analyst Rating Changes 07/18: (EXC) (LNC) (XLNX) Upgraded; (NTRS) (TLM) (MRK) Downgraded
-
Lazard Capital Upgrades Xilinx (XLNX) to Buy
-
Verastem (VSTM) Prices $51.9M Common Stock Offering
-
Insmed (INSM) Prices 6M Stock Offering at $10.40/Share
-
Regulus Therapeutics (RGLS) Prices 4.5M Shares at $9.50
-
Amid New CEO, In-Line Q4 Numbers, Best Chance for Emulex (ELX) is Buyout - Analyst
-
Notable Analyst Rating Changes 07/16: (GM) (BIDU) (SONS) Upgraded; (TSL) (EAT) (F) Downgraded
-
Lazard Firm on Fusion-io (FIO) Into Q4 Report Amid Management Shift; Maintains Buy, $23 PT
-
Management Exodus at ShoreTel (SHOR) Has Lazard Nervous; Cuts to Neutral
-
UPDATE: Lazard Capital Upgrades Sonus Networks, Inc. (SONS) to Buy
-
Weak Smartphone Environment Might Keep Apple (AAPL) at Bay Through Sept. Quarter - Lazard
-
Lazard Capital Downgrades ShoreTel (SHOR) to Neutral

